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Abstract
Background: Disease severity assessed by clinical scores in cystic fibrosis (CF) has been a topic of investigation for many
years, although a correlation of clinical scores with resting energy expenditure (REE) has not been described yet. We aimed to
assess disease severity as evaluated by the Shwachman–Kulczycki (SK) score and to correlate these findings with REE and
forced expiratory volume in 1 s (FEV ). Methods: Twenty-eight patients performed respiratory function testing (FEV ), and1 1
assessment of REE with open circuit indirect calorimetry. The SK score was evaluated according to general activity, physical
examination, nutrition and conventional chest X-ray findings. Results: Mean SK score was 75.3"15.7. Mean REE was 109.1%
of predicted vs. 96.5% predicted in 16 healthy subjects (Ps0.002). There was a significant correlation between the SK score and
REE (Ps0.001), the SK score and FEV (P-0.001) and REE and FEV (Ps0.034). Conclusions: The correlations between1 1
the SK score, REE and FEV demonstrate a close connection between disease severity, caloric requirement and lung damage.1
They confirm the clinical value of the SK score, which is easy to assess in a clinical setting.
 2003 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Maldigestion due to exocrine pancreatic insufficiency
is a major clinical manifestation in cystic fibrosis (CF).
It leads to massive fat and protein losses, and deterio-
ration of the nutritional status ensues. Therefore, optimal
nutrition is a major cornerstone in the management of
CF, and energy intake of at least 120% of the estimated
average requirement (EAR) is commonly advised in
patients with CF w1x. The actual caloric need, however,
is most exactly assessed by measuring total energy
expenditure (TEE), though indirect calorimetry is a
more convenient method. TEE can be estimated from
resting energy expenditure (REE), which has been
shown to account for 60–75% of TEE w2x.
The raised energy requirements in patients with CF
are caused by repetitive lung infections, lung inflam-
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mation, increased respiratory work and more uncertain,
the underlying genetic abnormality w3x. Good nutritional
status is important in patients with CF, and long-term
follow-up of CF patients has shown significantly better
survival in patients who achieve normal nutritional status
w4x. Disease severity assessed with clinical scores in CF
has been topic of decade’s of investigation w5x, though
a correlation of clinical scores with REE has not been
described yet. The aim of the present study was to
evaluate the validity of the Shwachman–Kulczycki (SK)
score by correlating the score to REE and forced
expiratory volume in 1 s (FEV ). We also wanted to1
see whether these correlations were different in our
paediatric compared to the adult patients with CF.
2. Materials and methods
Haukeland University Hospital serves as a regional
centre for patients with CF in western Norway. We
prospectively examined 13 female and 15 male patients
of age more than five years from our cohort of patients
with CF. The median age was 12.5 years (mean 14.7
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Fig. 1. Correlation between the Shwachman–Kulczycki score and rest-
ing energy expenditure (REE, percentage of predicted) in 28 patients
with CF; the graph reflects a regression line. Rsy0.576, Ps0.001.
years, S.D. 8.4). The CF diagnosis was made by
demonstration of repeated elevated sweat chloride con-
centrations (mean 100.1 mmolyl, S.D. 25.1) and typical
clinical manifestations in all patients. The mean forced
vital capacity was 95.3% of predicted (S.D. 22.7); the
mean forced expiratory volume in 1 s was 80.8% of
predicted (S.D. 23.2). Nine patients were found to be
homozygous for the dF508 mutation (32%); the remain-
ing 19 patients either had two other mutations (six
patients), one detectable mutation (five patients) or no
detectable mutation (eight patients).
Our patients attend the outpatient department every
2nd- 3rd-month, or more often when needed. Eight
patients (29%) have chronic lung infection with Pseu-
domonas aeruginosa. Twenty-one out of 28 patients
(75%) have been taking pancreatic enzyme supplemen-
tation (lipase 5000–10 000 IEykg body weight).
All patients had received conventional therapy for CF
for at least 6 months and they were in clinically stable
condition. Informed consent was obtained from patients
andyor their families. The regional ethical committee
approved our study protocol.
Clinical status was evaluated by the SK score w6x. A
maximum of 25 points and a minimum of one point are
awarded on a five-point scale to each of the following
categories: general activity, physical examination, nutri-
tional status and conventional chest X-ray findings. This
results in a global score from 4–100.
We performed standard computerised open-circuit
indirect calorimetry (Sensor Medics Vmax, California,
USA) after 12 h fasting, with at least four h restriction
of using b-2 inhalative agents. The patients were placed
under the canopy hood in a relaxed supine position.
Respiratory gas exchange was monitored for 10 min to
allow acclimatisation, followed by a subsequent 20–30
min measurement period. REE was calculated using the
abbreviated Weir formula w7x on a steady state period.
The steady state period was defined by a period of at
least five consecutive minutes where oxygen uptake and
ventilation varied by less than 10%, and respiratory
quotient varied by less than 5%.
Standard spirometry was assessed by Sensor Medics
Vmax (California, USA) equipment. We also examined
16 healthy subjects (seven females, nine males, median
age 12 years, range 8–33 years) with indirect calorim-
etry in order to verify our predicted values of REE.
Data analysis was performed using a commercially
available software package (SPSS). Descriptive statistics
included mean, minimum and maximum values, stan-
dard deviations and median. Differences in REE (per-
centage of predicted) between healthy subjects and CF
patients were tested using a Student’s t test and a
Wilcoxon–Mann–Whitney test. The relations between
SK score, FEV (percentage of predicted) and REE1
(percentage of predicted) were assessed by the Pearson
correlation coefficient. All reported P values are two-
tailed and P-0.05 was considered significant.
3. Results
The overall mean SK score for our CF population
was 75.3"15.7 (median 78.5), range 28–95. Mean
value of resting energy expenditure was 109.1"13.6%
of predicted in our CF population. In healthy subjects a
mean value of 96.5"8.7% predicted was found, which
was significantly lower (Ps0.002).
There was a significant correlation between the SK
score and REE (percentage of predicted, rsy0.576,
Ps0.001, Fig. 1). High resting energy expenditure was
correlated with a low SK score.
Furthermore, there was a significant correlation
between REE (percentage of predicted) and FEV (per-1
centage of predicted, rsy0.403, Ps0.034, Fig. 2).
High resting energy expenditure was correlated with low
FEV .1
Additionally, there was a highly significant correlation
between the SK score and FEV (percentage of predict-1
ed, rs0.796, P-0.001, Fig. 3). Low SK score was
correlated with low FEV .1
In our younger patients (Ns18, age -16 years) the
mean SK score was 80.1 (S.D. 11.2) compared to 66.8
(S.D. 19.5) in patients above 16 years of age (Ps0.03).
There was no significant correlation between REE (per-
centage of predicted) and the SK score in our young
patients, whereas, a significant correlation of FEV1
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Fig. 2. Correlation between resting energy expenditure (REE, per-
centage of predicted) and forced expiratory volume in 1 s (FEV ,1
percentage of predicted) in 28 patients with CF; the graph reflects a
regression line. Rsy0.403, Ps0.034.
Fig. 3. Correlation between the Shwachman–Kulczycki score and
forced expiratory volume in 1 s (FEV , percentage of predicted) in1
28 patients with CF; the graph reflects a regression line. Rs0.796,
P-0.001.
(percentage of predicted) and the SK score (rs0.656,
Ps0.003) was demonstrated in this group.
4. Discussion
The Shwachman–Kulczycki score has been used for
almost half a century to assess disease severity in
patients with CF, and it is still the most common clinical
CF score w8,9x. Like other clinical CF scores w10,11x
the SK score aims to provide easy accessible evaluation
of a patient’s overall condition according to the main
categories general activity, physical examination, nutri-
tional status and conventional chest X-ray findings.
Although none of these items allow precise evaluation
alone, the context of all items together gives information
about the most life-limiting factors in CF, the degree of
pulmonary destruction and malnutrition.
In our patients, we found a statistical highly signifi-
cant correlation between the SK score and both REE
and lung function as measured by FEV . Moreover,1
REE correlated significantly with FEV , which is in1
accordance with previously reported findings by Fried
and co-workers w12x. In their study, they found a strong
correlation between declining pulmonary function and
increased resting energy expenditure. Once FEV falls1
below 75% of predicted values, the REE raises in a
curvilinear fashion. Buchdahl and colleagues demon-
strated a significant correlation between increased REE
and impaired pulmonary function as measured by the
ratio of FEV to FVC (forced vital capacity) w3x. In1
well-nourished CF males with well-preserved lung func-
tion, there is only little, if any increase in REE w12x,
although Bowler et al. found increased REE in CF
patients with mild lung involvement as well w13x. Thus,
disease severity seems to have an impact on resting
energy expenditure. We have previously presented data
on high-resolution computer tomography (HRCT) find-
ings in our CF patients, and we found a significant
correlation between a commonly used HRCT score and
REE w14x. We could also confirm a significant correla-
tion between HRCT and the SK score both in our
paediatric and the adult patients (data not presented
here) as reported by Demirkazik and colleagues w15x.
Other investigators, however, could not find a correlation
between REE and pulmonary function as measured by
FEV w16,17x.1
In the present study, the mean SK score in our CF
population was 75, indicating mild to moderate disease.
Significantly lower values were found in patients older
than 16 years, reflecting more advanced disease in the
adult CF population. The correlation between SK score
and resting energy expenditure was, however, not sig-
nificant for patients younger than 16 years. However,
the correlation between SK score and FEV was highly1
significant in this group. Taken into account our previous
findings that HRCT score and SK were strongly corre-
lated regardless of age, this lack of statistically signifi-
cance among our younger patients may indicate a minor
impact of mild disease on resting energy expenditure in
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CF. However, these findings must be interpreted with
caution due to small sample sizes.
Increased REE in patients with CF is well known
w4,18x and probably reflects repetitive lung infections,
lung inflammation with elevated levels of cytokines and
increased respiratory effort. The genetic defect itself
may have a minor effect on REE, although recent studies
have not revealed a primary defect of energy metabolism
in subjects with CF w19,20x. The degree of parenchymal
lung damage seems to play a major role in the interaction
between REE and the SK score, which thereby confirms
the findings of Fried and co-workers w12x.
There seems to be a close correlation between disease
severity evaluated by means of the SK score and resting
energy expenditure. Similar correlations have been
reported between the SK score and high-resolution
computer tomography findings w15x. Our results emphas-
ise the clinical value of the SK score, which in contrast
to the other methods is easy to assess. The use of the
SK score in evaluation of disease severity and progres-
sion in CF is still valid, especially in older patients.
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